Telecare for teenagers with type 1 diabetes: A trial

F. Cadario, M. Binotti, M. Brustia, F. Mercandino, G. Moreno, S. Esposito, R. Baldelli, G. Bona

Research output: Contribution to journalArticle

Abstract

Aim. The aim of this paper was to test in teenagers with type 1 diabetes mellitus (T1DM) the Glucobeeb (Gb), a web based tool to support the diabetes care. Methods. Gb transfers glucometer's data by phone and Internet to the PC of practitioner in files dedicated to each patient; the response returns to patient as 1-min vocal message. From outpatients paediatric clinic 28 teenagers (mean 14.8 years, range 10-20, male 14) with T1DM on multiple daily injections insulin therapy, with glicated haemoglobin (HbA1c) over 7% and >2 years' duration of the disease (9.1 years, range 2-15), were consequently randomized to telecare (glucometer transmission with feedback, group A) or control (standard communication by phone and face-to-face visits, group B). Glycaemia was tested four times per day and data transmitted every 2 weeks; clinician feedback returned within the following week. Two controls were excluded after randomization. Outcomes of 14 patients of A were compared with 12 of B. Results. In intervention group average HbA1c% decreased from baseline at 3 and 6 months in comparison with controls (9.5, 9.0, 9-1, vs 9.1, 9-4, 9.4 respectively). Controls after 6 months were introduced to Gb, and similar trend of HbA1c was observed in the following examinations at 3 and 6 month (9.4, 8.9, 8.7). Then, in both groups HbA1c after 12 months of Gb increased, and after 18 reduced (A: 9-2, and 8.8, B 9-1 and 8.5 respectively). The enhancement of HbA1c from baseline to end was significant (P=0.01). Conclusion. The tool improves metabolic control in teenagers with T1DM.

Original languageEnglish
Pages (from-to)299-305
Number of pages7
JournalMinerva Pediatrica
Volume59
Issue number4
Publication statusPublished - Aug 2007

Fingerprint

Type 1 Diabetes Mellitus
Random Allocation
Ambulatory Care Facilities
Internet
Hemoglobins
Communication
Insulin
Pediatrics
Injections
Therapeutics

Keywords

  • Adolescence
  • Child
  • Diabetes mellitus type 1
  • Telemedicine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Cadario, F., Binotti, M., Brustia, M., Mercandino, F., Moreno, G., Esposito, S., ... Bona, G. (2007). Telecare for teenagers with type 1 diabetes: A trial. Minerva Pediatrica, 59(4), 299-305.

Telecare for teenagers with type 1 diabetes : A trial. / Cadario, F.; Binotti, M.; Brustia, M.; Mercandino, F.; Moreno, G.; Esposito, S.; Baldelli, R.; Bona, G.

In: Minerva Pediatrica, Vol. 59, No. 4, 08.2007, p. 299-305.

Research output: Contribution to journalArticle

Cadario, F, Binotti, M, Brustia, M, Mercandino, F, Moreno, G, Esposito, S, Baldelli, R & Bona, G 2007, 'Telecare for teenagers with type 1 diabetes: A trial', Minerva Pediatrica, vol. 59, no. 4, pp. 299-305.
Cadario F, Binotti M, Brustia M, Mercandino F, Moreno G, Esposito S et al. Telecare for teenagers with type 1 diabetes: A trial. Minerva Pediatrica. 2007 Aug;59(4):299-305.
Cadario, F. ; Binotti, M. ; Brustia, M. ; Mercandino, F. ; Moreno, G. ; Esposito, S. ; Baldelli, R. ; Bona, G. / Telecare for teenagers with type 1 diabetes : A trial. In: Minerva Pediatrica. 2007 ; Vol. 59, No. 4. pp. 299-305.
@article{8268e729ad6b4671a3c4520a5f5ca633,
title = "Telecare for teenagers with type 1 diabetes: A trial",
abstract = "Aim. The aim of this paper was to test in teenagers with type 1 diabetes mellitus (T1DM) the Glucobeeb (Gb), a web based tool to support the diabetes care. Methods. Gb transfers glucometer's data by phone and Internet to the PC of practitioner in files dedicated to each patient; the response returns to patient as 1-min vocal message. From outpatients paediatric clinic 28 teenagers (mean 14.8 years, range 10-20, male 14) with T1DM on multiple daily injections insulin therapy, with glicated haemoglobin (HbA1c) over 7{\%} and >2 years' duration of the disease (9.1 years, range 2-15), were consequently randomized to telecare (glucometer transmission with feedback, group A) or control (standard communication by phone and face-to-face visits, group B). Glycaemia was tested four times per day and data transmitted every 2 weeks; clinician feedback returned within the following week. Two controls were excluded after randomization. Outcomes of 14 patients of A were compared with 12 of B. Results. In intervention group average HbA1c{\%} decreased from baseline at 3 and 6 months in comparison with controls (9.5, 9.0, 9-1, vs 9.1, 9-4, 9.4 respectively). Controls after 6 months were introduced to Gb, and similar trend of HbA1c was observed in the following examinations at 3 and 6 month (9.4, 8.9, 8.7). Then, in both groups HbA1c after 12 months of Gb increased, and after 18 reduced (A: 9-2, and 8.8, B 9-1 and 8.5 respectively). The enhancement of HbA1c from baseline to end was significant (P=0.01). Conclusion. The tool improves metabolic control in teenagers with T1DM.",
keywords = "Adolescence, Child, Diabetes mellitus type 1, Telemedicine",
author = "F. Cadario and M. Binotti and M. Brustia and F. Mercandino and G. Moreno and S. Esposito and R. Baldelli and G. Bona",
year = "2007",
month = "8",
language = "English",
volume = "59",
pages = "299--305",
journal = "Minerva Pediatrica",
issn = "0026-4946",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - Telecare for teenagers with type 1 diabetes

T2 - A trial

AU - Cadario, F.

AU - Binotti, M.

AU - Brustia, M.

AU - Mercandino, F.

AU - Moreno, G.

AU - Esposito, S.

AU - Baldelli, R.

AU - Bona, G.

PY - 2007/8

Y1 - 2007/8

N2 - Aim. The aim of this paper was to test in teenagers with type 1 diabetes mellitus (T1DM) the Glucobeeb (Gb), a web based tool to support the diabetes care. Methods. Gb transfers glucometer's data by phone and Internet to the PC of practitioner in files dedicated to each patient; the response returns to patient as 1-min vocal message. From outpatients paediatric clinic 28 teenagers (mean 14.8 years, range 10-20, male 14) with T1DM on multiple daily injections insulin therapy, with glicated haemoglobin (HbA1c) over 7% and >2 years' duration of the disease (9.1 years, range 2-15), were consequently randomized to telecare (glucometer transmission with feedback, group A) or control (standard communication by phone and face-to-face visits, group B). Glycaemia was tested four times per day and data transmitted every 2 weeks; clinician feedback returned within the following week. Two controls were excluded after randomization. Outcomes of 14 patients of A were compared with 12 of B. Results. In intervention group average HbA1c% decreased from baseline at 3 and 6 months in comparison with controls (9.5, 9.0, 9-1, vs 9.1, 9-4, 9.4 respectively). Controls after 6 months were introduced to Gb, and similar trend of HbA1c was observed in the following examinations at 3 and 6 month (9.4, 8.9, 8.7). Then, in both groups HbA1c after 12 months of Gb increased, and after 18 reduced (A: 9-2, and 8.8, B 9-1 and 8.5 respectively). The enhancement of HbA1c from baseline to end was significant (P=0.01). Conclusion. The tool improves metabolic control in teenagers with T1DM.

AB - Aim. The aim of this paper was to test in teenagers with type 1 diabetes mellitus (T1DM) the Glucobeeb (Gb), a web based tool to support the diabetes care. Methods. Gb transfers glucometer's data by phone and Internet to the PC of practitioner in files dedicated to each patient; the response returns to patient as 1-min vocal message. From outpatients paediatric clinic 28 teenagers (mean 14.8 years, range 10-20, male 14) with T1DM on multiple daily injections insulin therapy, with glicated haemoglobin (HbA1c) over 7% and >2 years' duration of the disease (9.1 years, range 2-15), were consequently randomized to telecare (glucometer transmission with feedback, group A) or control (standard communication by phone and face-to-face visits, group B). Glycaemia was tested four times per day and data transmitted every 2 weeks; clinician feedback returned within the following week. Two controls were excluded after randomization. Outcomes of 14 patients of A were compared with 12 of B. Results. In intervention group average HbA1c% decreased from baseline at 3 and 6 months in comparison with controls (9.5, 9.0, 9-1, vs 9.1, 9-4, 9.4 respectively). Controls after 6 months were introduced to Gb, and similar trend of HbA1c was observed in the following examinations at 3 and 6 month (9.4, 8.9, 8.7). Then, in both groups HbA1c after 12 months of Gb increased, and after 18 reduced (A: 9-2, and 8.8, B 9-1 and 8.5 respectively). The enhancement of HbA1c from baseline to end was significant (P=0.01). Conclusion. The tool improves metabolic control in teenagers with T1DM.

KW - Adolescence

KW - Child

KW - Diabetes mellitus type 1

KW - Telemedicine

UR - http://www.scopus.com/inward/record.url?scp=35848948872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848948872&partnerID=8YFLogxK

M3 - Article

C2 - 17947836

AN - SCOPUS:35848948872

VL - 59

SP - 299

EP - 305

JO - Minerva Pediatrica

JF - Minerva Pediatrica

SN - 0026-4946

IS - 4

ER -